You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 4 No. 4, Oct-Dec 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Biomaterials and Implants
 •Cosmetic Surgery/ Procedures
 •Alert me on articles by topic

Rejuvenation of the Aging Lip With an Injectable Acellular Dermal Graft (Cymetra)

Anthony P. Sclafani, MD; Thomas Romo III, MD; Andrew A. Jacono, MD

Arch Facial Plast Surg. 2002;4:252-257.

Objective  To evaluate the effects of Cymetra (micronized AlloDerm tissue) in rejuvenating the aging and atrophic lip.

Patients  Forty-four patients aged 32 to 80 years who reported age-related changes in the size and contour of the upper lip.

Methods  Patients were randomized to treatment with either Cymetra or glutaraldehyde cross-linked bovine collagen (Zyplast). Standardized photographs of each subject were taken before and after treatment initially and 3, 6, 9, and 12 months after initial treatment. Patients were monitored for signs of hypersensitivity, infection, and inflammation.

Main Outcome Measures  Digital photographs were analyzed for changes in the nasolabial angle, percentage of the total lip accounted for by the exposed red lip in the midline and on the lateral view, the visible red upper and lower lip surface areas, and the anterior projection of the upper and lower lips.

Results  All patients tolerated treatment well without any significant local or systemic complications. Nineteen patients were treated with Cymetra and 25 with Zyplast. Cymetra-treated patients were more likely than Zyplast-treated patients at 12 months (3 months after the previous treatment) to have increased the percentage of red lip in the midline (84.6% vs 38.9%; P = .01), the vermilion height in the upper lip midline (84.6% vs 38.9%; P = .01), and the exposed red lower lip on the lateral view (69.2% vs 33.3%; P = .048) by at least 20%; increased the lower lip projection by 0.5 mm or more (69.2% vs 27.8%; P = .02); and decreased the nasolabial angle by at least 10° (46.2% vs 16.7%; P = .07).

Conclusions  Cymetra is a suspension of particulate dermal matrix that seems to increase the upper lip bulk, vermilion, and lower lip projection after a threshold of Cymetra has been administered. There are few differences in any measured long-term (3 months after treatment) variables until the 12-month visit, when there were statistically significantly more Cymetra-treated patients with improved lip aesthetics than those treated with Zyplast. With repeated treatments, Cymetra seems to accumulate, producing a long-term effect superior to Zyplast in many patients.


From the Division of Facial Plastic Surgery, The New York Eye and Ear Infirmary, New York (Dr Sclafani); the Department of Otolaryngology–Head and Neck Surgery, New York Medical College, Valhalla (Drs Sclafani and Romo); and the Division of Facial Plastic Surgery, Lenox Hill Hospital, New York (Dr Romo). Dr Jacono is in private practice in Great Neck, NY. Dr Romo is an unpaid medical advisor to LifeCell Corp, Branchburg, NJ. No author holds any financial interest in LifeCell Corp.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quantitative Analysis of Lip Appearance After V-Y Lip Augmentation
Jacono and Quatela
Arch Facial Plast Surg 2004;6:172-177.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.